Model
Edge
Theravance Biopharma Inc.
TBPH
Filing Type
8-K
Filing Date
3/2/2026
Updated
3/3/26, 6:40 AM
Filing
8-K
Earnings Release
Exhibits
8-K
Financial Results, Costs of Shutting Down or Selling Parts of the Business, Reg. FD
EX-99.1
Financial Results, Costs of Shutting Down or Selling Parts of the Business, Reg. FD
GRAPHIC
Graphic